menu
    • menu

    Company profile for Seed Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Seed Therapeutics is a global research company uniquely focused on harnessing and engineering molecules that use “molecular glues” to attack protein targets previously believed to be ”undruggable.Unlike proteolysis targeting chimera (PROTAC)-based strategies, Seed Therapeutics focuses on discovering “molecular glues” with properties that have the potential to overcome the significant challenges facing any drug candid...
    Seed Therapeutics is a global research company uniquely focused on harnessing and engineering molecules that use “molecular glues” to attack protein targets previously believed to be ”undruggable.Unlike proteolysis targeting chimera (PROTAC)-based strategies, Seed Therapeutics focuses on discovering “molecular glues” with properties that have the potential to overcome the significant challenges facing any drug candidate advancing through the different stages of drug development, leading to drug approval. Seed Therapeutics is pioneering the science of improving human health.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Seed TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    28 Liberty Street, 39th Floor New York, NY 10005
    Telephone
    Telephone
    +1 (646) 859-2751
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.seedtherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SEED Therapeutics Gets IND Clearance From China's NMPA
    SEED Therapeutics Gets IND Clearance From China's NMPA

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186079/0/en/SEED-Therapeutics-Receives-IND-Clearance-from-China-s-NMPA-for-ST-01156.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    SEED Therapeutics Completes $30 Million Series A-3 Financing
    SEED Therapeutics Completes $30 Million Series A-3 Financing

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3154545/0/en/SEED-Therapeutics-Completes-30-Million-Series-A-3-Financing.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share
    20 Years of Ubiquitin Revolution: Honoring A. Hershko
    20 Years of Ubiquitin Revolution: Honoring A. Hershko

    09 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/09/3146743/0/en/20-Years-of-the-Ubiquitin-Revolution-Honoring-Nobel-Laureate-Professor-Avram-Hershko-and-the-Future-of-Targeted-Protein-Degradation.html

    GLOBENEWSWIRE
    09 Sep 2025
    Share Share
    SEED Therapeutics Finalist for 2025 Prix Galien USA 'Best
    SEED Therapeutics Finalist for 2025 Prix Galien USA 'Best

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133283/0/en/SEED-Therapeutics-Named-Finalist-for-2025-Prix-Galien-USA-Best-Start-Up-Award.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share
    FDA Approves IND for SEED's RBM39 Degrader ST-01156
    FDA Approves IND for SEED's RBM39 Degrader ST-01156

    11 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/11/3130780/0/en/FDA-Clears-IND-for-SEED-Therapeutics-RBM39-Degrader-ST-01156.html

    GLOBENEWSWIRE
    11 Aug 2025
    Share Share
    SEED Therapeutics Names Dr. Bill Desmarais CFO and CBO
    SEED Therapeutics Names Dr. Bill Desmarais CFO and CBO

    09 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/09/3095725/0/en/SEED-Therapeutics-Appoints-Dr-Bill-Desmarais-as-Chief-Financial-Officer-and-Chief-Business-Officer.html

    GLOBENEWSWIRE
    09 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search